Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.125
-0.025 (-2.17%)
Apr 29, 2026, 4:00 PM EDT - Market closed
Inovio Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 44.27 | 65.81 | 14.31 | 46.33 | 71.14 | Upgrade
|
| Short-Term Investments | 14.24 | 28.3 | 130.98 | 206.67 | 330.17 | Upgrade
|
| Cash & Short-Term Investments | 58.51 | 94.11 | 145.29 | 253 | 401.31 | Upgrade
|
| Cash Growth | -37.83% | -35.23% | -42.57% | -36.96% | -2.51% | Upgrade
|
| Receivables | 0 | 1.2 | 2.41 | 11.74 | 8.03 | Upgrade
|
| Prepaid Expenses | 2.61 | 2.52 | 5.41 | 20.51 | 39.1 | Upgrade
|
| Other Current Assets | - | - | - | 30 | - | Upgrade
|
| Total Current Assets | 61.12 | 97.83 | 153.11 | 315.24 | 448.44 | Upgrade
|
| Property, Plant & Equipment | 9.07 | 11.77 | 14.45 | 17.96 | 29.02 | Upgrade
|
| Long-Term Investments | 2.1 | 1.61 | 2.78 | 2.01 | 3.91 | Upgrade
|
| Goodwill | - | - | - | 10.51 | 10.51 | Upgrade
|
| Other Intangible Assets | - | - | - | 2.13 | 2.63 | Upgrade
|
| Other Long-Term Assets | 2.01 | 1.98 | 0.61 | 0.68 | 1.43 | Upgrade
|
| Total Assets | 74.31 | 113.2 | 170.95 | 348.53 | 495.94 | Upgrade
|
| Accounts Payable | 2.62 | 6.44 | 4.65 | 21.08 | 27.97 | Upgrade
|
| Accrued Expenses | 9.16 | 13.13 | 18.64 | 26.42 | 30.55 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 16.77 | - | - | Upgrade
|
| Current Portion of Leases | 2.82 | 2.5 | 2.41 | 2.8 | 2.6 | Upgrade
|
| Current Unearned Revenue | - | - | 0.11 | 2.56 | 4.62 | Upgrade
|
| Other Current Liabilities | 29.07 | 13.26 | - | 44 | - | Upgrade
|
| Total Current Liabilities | 43.67 | 35.33 | 42.57 | 96.87 | 65.74 | Upgrade
|
| Long-Term Debt | - | - | - | 16.61 | 14.96 | Upgrade
|
| Long-Term Leases | 6.55 | 9.37 | 11.03 | 12.66 | 15.46 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.06 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | 0.03 | 0.03 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.01 | Upgrade
|
| Total Liabilities | 50.21 | 44.69 | 53.6 | 126.17 | 96.27 | Upgrade
|
| Common Stock | 0.07 | 0.04 | 0.02 | 0.02 | 0.22 | Upgrade
|
| Additional Paid-In Capital | 1,840 | 1,799 | 1,741 | 1,711 | 1,610 | Upgrade
|
| Retained Earnings | -1,815 | -1,730 | -1,623 | -1,488 | -1,210 | Upgrade
|
| Comprehensive Income & Other | -0.64 | -0.68 | -0.66 | -0.7 | -0.28 | Upgrade
|
| Total Common Equity | 24.1 | 68.5 | 117.35 | 222.36 | 399.67 | Upgrade
|
| Shareholders' Equity | 24.1 | 68.5 | 117.35 | 222.36 | 399.67 | Upgrade
|
| Total Liabilities & Equity | 74.31 | 113.2 | 170.95 | 348.53 | 495.94 | Upgrade
|
| Total Debt | 9.37 | 11.87 | 30.21 | 32.07 | 33.02 | Upgrade
|
| Net Cash (Debt) | 49.14 | 82.25 | 115.08 | 220.92 | 368.29 | Upgrade
|
| Net Cash Growth | -40.25% | -28.53% | -47.91% | -40.01% | -1.16% | Upgrade
|
| Net Cash Per Share | 1.05 | 3.03 | 5.19 | 11.11 | 21.16 | Upgrade
|
| Filing Date Shares Outstanding | 69.09 | 36.67 | 23.37 | 21.68 | 18.12 | Upgrade
|
| Total Common Shares Outstanding | 69 | 36.1 | 22.79 | 21.09 | 18.12 | Upgrade
|
| Working Capital | 17.45 | 62.5 | 110.54 | 218.37 | 382.7 | Upgrade
|
| Book Value Per Share | 0.35 | 1.90 | 5.15 | 10.54 | 22.06 | Upgrade
|
| Tangible Book Value | 24.1 | 68.5 | 117.35 | 209.72 | 386.53 | Upgrade
|
| Tangible Book Value Per Share | 0.35 | 1.90 | 5.15 | 9.94 | 21.34 | Upgrade
|
| Machinery | 8.13 | 8.36 | 9.9 | 13.49 | 20.59 | Upgrade
|
| Leasehold Improvements | 11.82 | 11.76 | 15.92 | 15.8 | 15.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.